Canadian Thalidomide Survivors Support Program
Thalidomide Survivors Contribution Program Class Proceeding – Notice of Settlement Approval Hearing on February 26-27, 2020. Click here for more information.
On May 8, 2020, the Federal Court approved the settlement and Class Counsel’s fee request in the class proceeding regarding the 2015 Thalidomide Survivors Contribution Program. The motion for costs was denied. Copies of these orders and the reasons for the decision can be found at Class Counsels' website at: Thalidomide Survivors Contribution Program Class Proceeding
CTSSP Application Deadline:
Step 1 – Preliminary Screening Applications are now available for any living individual who believes that they are a Thalidomide Survivor, including those previously denied under the 1991 EAP or the 2015 TSCP. Click here to download the form or call 1-877-507-7706 (TTY: 1-877-627-7027) to have one sent to you. The CTSSP Application deadline is postmarked by June 3, 2024 to the Administrator.
Confirmed Survivors who are currently at a level 1 or a level 2, may request reassessment of their health status for the 2019-2020 FY anytime between April 1, 2019 and March 31, 2020. Click here to download the application.
EMAF applications are now being accepted for the 2019-2020 FY. Confirmed Survivors may submit up to a maximum of two applications per year anytime between April 1, 2019 and March 31, 2020. Click here to download the application.
You may also call the Administrator at 1-877-507-7706 (TTY: 1-877-627-7027) or by email to email@example.com to have any of the forms sent to you by mail or email.
Coronavirus (COVID-19) Update
These are unprecedented times for all of us. We are closely monitoring developments and will post any changes to our service delivery here. At this time, our information line remains open Monday through Friday from 9 a.m. to 5 p.m. Eastern time; however, recent surges in land line and cellular phone usage may saturate national service provider networks causing disruption to our call centre service. As an alternative, you may also contact us by email or mail. We hope that you are safe and well.
The Canadian Thalidomide Survivors Support Program (“CTSSP”) is a financial support package for Canadian Thalidomide Survivors, announced by the Minister of Health on January 9, 2019.
Thalidomide Survivors who were already confirmed under the Government of Canada’s 1991 Extraordinary Assistance Plan (”EAP”) for Thalidomide Victims and/or the former Thalidomide Survivors Contribution Program (”TSCP”) will be transferred automatically to the new Canadian Thalidomide Survivors Support Program (“CTSSP”) without the need to re-apply.
Anyone who believes that they are a Thalidomide survivor, including those previously refused by the 1991 EAP or the 2015 TSCP, may apply for assessment under the new CTSSP program.
What is the purpose of the CTSSP?
The CTSSP is intended to contribute to meeting the needs of Thalidomide Survivors for the remainder of their lives so that they may age with dignity.
What does the CTSSP include?
Any individual who believes that they are a Thalidomide Survivor, including those previously denied under the 1991 EAP or the 2015 TSCP, can apply for assessment under the CTSSP. Click here for more information.
Thalidomide Survivors who were already confirmed under the 1991 EAP and/or the former TSCP will automatically be transferred to the new Canadian Thalidomide Survivors Support Program (“CTSSP”) without the need to re-apply.
Health Canada will contact existing Confirmed Thalidomide Survivors directly to arrange payment of the CTSSP ex gratia $125,000 top up payment.
Annual ongoing support payments will continue uninterrupted for the Confirmed Thalidomide Survivor’s lifetime.
Confirmed Survivor Benefits